Boston Scientific Shares Drop Despite Strong Q4 as 2026 Outlook Disappoints

Boston Scientific (BSX) reports strong Q4 2025 earnings but shares fall over 10% on modest 2026 guidance. Revenue growth expected to slow to 10-11% from 15.8% in 2026.